𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I Trial of Pirfenidone in Children with Neurofibromatosis 1 and Plexiform Neurofibromas

✍ Scribed by Dusica Babovic-Vuksanovic; Brigitte C. Widemann; Eva Dombi; Andrea Gillespie; Pamela L. Wolters; Mary Anne Toledo-Tamula; Brian P. O’Neill; Elizabeth Fox; Tobey MacDonald; Heather Beck; Roger J. Packer

Book ID
116825118
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
122 KB
Volume
36
Category
Article
ISSN
0887-8994

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF1 mutations in neurofibromatosis 1 pat
NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas
✍ Lan Kluwe; Reinhard E. Friedrich; Bruce Korf; Raimund Fahsold; Victor-F. Mautner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Neurofibromatosis 1 (NF1) is an autosomal dominant disorder caused by genetic alterations of the NF1 gene on 17q11.2. About 30% of NF1 patients develop plexiform neurofibromas (PNFs), which often cause severe clinical deficits. To determine whether there is a certain genotype underlying PNFs or subt

Clinic-based study of plexiform neurofib
Clinic-based study of plexiform neurofibromas in neurofibromatosis 1
✍ Waggoner, Darrel J.; Towbin, Jennifer; Gottesman, Gary; Gutmann, David H. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB 👁 1 views

Individuals with neurofibromatosis 1 (NF1) develop both benign and malignant tumors at an increased frequency. One of the most common benign tumors in NF1 is the plexiform neurofibroma. These tumors cause significant morbidity and mortality on account of their propensity to grow and affect adjacent